학술논문

Dashboard-Driven Accelerated Infliximab Induction Dosing Increases Infliximab Durability and Reduces Immunogenicity
Document Type
Article
Source
In: Inflammatory Bowel Diseases. (Inflammatory Bowel Diseases, 1 September 2022, 28(9):1375-1385)
Subject
Language
English
ISSN
15364844
10780998